ArticleSensors (Basel, Switzerland)2025
AI-Powered Noninvasive Electrocardiographic Imaging Using the Priori-to-Attention Network (P2AN) for Wearable Health Monitoring.
Article in Sensors (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
The rapid development of smart wearable devices has significantly advanced noninvasive, continuous health monitoring, enabling real-time collection of vital biosignals. Electrocardiographic imaging (ECGI), a noninvasive technique that reconstructs transmembrane potential (TMP) from body surface potential, has emerged as a promising method for reflecting cardiac electrical activity. However, the ECG inverse problem's inherent instability has hindered its practical application. To address this, we introduce a novel Priori-to-Attention Network (P2AN) that enhances the stability of ECGI solutions. By leveraging the one-dimensional nature of electrical signals and the body's electrical propagation properties, P2AN uses small-scale convolutions for attention computation, integrating a priori physiological knowledge via cross-attention mechanisms. This approach eliminates the need for clinical TMP measurements and improves solution accuracy through normalization constraints. We evaluate the method's effectiveness in diagnosing myocardial ischemia and ventricular hypertrophy, demonstrating significant improvements in TMP reconstruction and lesion localization. Moreover, P2AN exhibits high robustness in noisy environments, making it highly suitable for integration with wearable electrocardiographic clothing. By improving spatiotemporal accuracy and noise resilience, P2AN offers a promising solution for noninvasive, real-time cardiovascular monitoring using AI-powered wearable devices.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.